IBDEI14Y ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20036,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,20037,0)
 ;;=272.2^^105^1241^42
 ;;^UTILITY(U,$J,358.3,20037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20037,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,20037,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,20037,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,20038,0)
 ;;=401.9^^105^1241^43
 ;;^UTILITY(U,$J,358.3,20038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20038,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,20038,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,20038,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,20039,0)
 ;;=244.9^^105^1241^44
 ;;^UTILITY(U,$J,358.3,20039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20039,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,20039,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,20039,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,20040,0)
 ;;=790.21^^105^1241^45
 ;;^UTILITY(U,$J,358.3,20040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20040,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,20040,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,20040,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,20041,0)
 ;;=790.5^^105^1241^51
 ;;^UTILITY(U,$J,358.3,20041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20041,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,20041,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,20041,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,20042,0)
 ;;=724.2^^105^1241^52
 ;;^UTILITY(U,$J,358.3,20042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20042,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,20042,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,20042,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,20043,0)
 ;;=412.^^105^1241^56
 ;;^UTILITY(U,$J,358.3,20043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20043,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,20043,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,20043,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,20044,0)
 ;;=250.60^^105^1241^58
 ;;^UTILITY(U,$J,358.3,20044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20044,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,20044,1,5,0)
 ;;=5^Neuropathy,Diabetic
 ;;^UTILITY(U,$J,358.3,20044,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,20045,0)
 ;;=V15.81^^105^1241^59
 ;;^UTILITY(U,$J,358.3,20045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20045,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,20045,1,5,0)
 ;;=5^Noncompliance
 ;;^UTILITY(U,$J,358.3,20045,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,20046,0)
 ;;=278.00^^105^1241^60
 ;;^UTILITY(U,$J,358.3,20046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20046,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,20046,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,20046,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,20047,0)
 ;;=278.02^^105^1241^62
 ;;^UTILITY(U,$J,358.3,20047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20047,1,4,0)
 ;;=4^278.02
 ;;^UTILITY(U,$J,358.3,20047,1,5,0)
 ;;=5^Overweight
 ;;^UTILITY(U,$J,358.3,20047,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,20048,0)
 ;;=715.90^^105^1241^61
 ;;^UTILITY(U,$J,358.3,20048,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20048,1,4,0)
 ;;=4^715.90
 ;;^UTILITY(U,$J,358.3,20048,1,5,0)
 ;;=5^Osteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,20048,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,20049,0)
 ;;=728.71^^105^1241^65
 ;;^UTILITY(U,$J,358.3,20049,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20049,1,4,0)
 ;;=4^728.71
 ;;^UTILITY(U,$J,358.3,20049,1,5,0)
 ;;=5^Plantar Fascitis
 ;;^UTILITY(U,$J,358.3,20049,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,20050,0)
 ;;=486.^^105^1241^66
 ;;^UTILITY(U,$J,358.3,20050,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20050,1,4,0)
 ;;=4^486.
 ;;
 ;;$END ROU IBDEI14Y
